Table of Contents United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Report 2018 1 Paroxysmal Nocturnal Hemoglobinuria Treatment Overview 1.1 Product Overview and Scope of Paroxysmal Nocturnal Hemoglobinuria Treatment 1.2 Classification of Paroxysmal Nocturnal Hemoglobinuria Treatment by Product Category 1.2.1 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Sales Volume) Comparison by Type (2013-2025) 1.2.2 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2017 1.2.3 ACH-4471 1.2.4 ALN-CC5 1.2.5 ALXN-1210 1.2.6 AMY-101 1.2.7 APL-2 1.2.8 Others 1.3 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market by Application/End Users 1.3.1 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Consumption) and Market Share Comparison by Application (2013-2025) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market by Region 1.4.1 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Value) Comparison by Region (2013-2025) 1.4.2 The West Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2013-2025) 1.4.3 Southwest Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2013-2025) 1.4.4 The Middle Atlantic Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2013-2025) 1.4.5 New England Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2013-2025) 1.4.6 The South Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2013-2025) 1.4.7 The Midwest Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2013-2025) 1.5 United States Market Size (Value and Volume) of Paroxysmal Nocturnal Hemoglobinuria Treatment (2013-2025) 1.5.1 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Growth Rate (2013-2025) 1.5.2 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue and Growth Rate (2013-2025) 2 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Competition by Players/Suppliers 2.1 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Market Share of Key Players/Suppliers (2013-2018) 2.2 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue and Share by Players/Suppliers (2013-2018) 2.3 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Average Price by Players/Suppliers (2013-2018) 2.4 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Competitive Situation and Trends 2.4.1 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Concentration Rate 2.4.2 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers Paroxysmal Nocturnal Hemoglobinuria Treatment Manufacturing Base Distribution, Sales Area, Product Type 3 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (Volume) and Revenue (Value) by Region (2013-2018) 3.1 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Market Share by Region (2013-2018) 3.2 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue and Market Share by Region (2013-2018) 3.3 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Price by Region (2013-2018) 4 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018) 4.1 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Market Share by Type (Product Category) (2013-2018) 4.2 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue and Market Share by Type (2013-2018) 4.3 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Price by Type (2013-2018) 4.4 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Growth Rate by Type (2013-2018) 5 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (Volume) by Application (2013-2018) 5.1 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales and Market Share by Application (2013-2018) 5.2 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Growth Rate by Application (2013-2018) 5.3 Market Drivers and Opportunities 6 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Players/Suppliers Profiles and Sales Data 6.1 Achillion Pharmaceuticals Inc 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Category, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018) 6.1.4 Main Business/Business Overview 6.2 Akari Therapeutics Plc 6.2.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Category, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018) 6.2.4 Main Business/Business Overview 6.3 Alexion Pharmaceuticals Inc 6.3.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Category, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018) 6.3.4 Main Business/Business Overview 6.4 Alnylam Pharmaceuticals Inc 6.4.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Category, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018) 6.4.4 Main Business/Business Overview 6.5 Amgen Inc 6.5.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Category, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018) 6.5.4 Main Business/Business Overview 6.6 Apellis Pharmaceuticals Inc 6.6.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Category, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018) 6.6.4 Main Business/Business Overview 6.7 F. Hoffmann-La Roche Ltd 6.7.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Category, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018) 6.7.4 Main Business/Business Overview 6.8 ISU ABXIS Co Ltd 6.8.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Category, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018) 6.8.4 Main Business/Business Overview 6.9 Novartis AG 6.9.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Category, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018) 6.9.4 Main Business/Business Overview 6.10 NovelMed Therapeutics Inc 6.10.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Product Category, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales, Revenue, Price and Gross Margin (2013-2018) 6.10.4 Main Business/Business Overview 6.11 Omeros Corp 6.12 Ra Pharmaceuticals Inc 6.13 Regeneron Pharmaceuticals Inc 6.14 Regenesance BV 7 Paroxysmal Nocturnal Hemoglobinuria Treatment Manufacturing Cost Analysis 7.1 Paroxysmal Nocturnal Hemoglobinuria Treatment Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Paroxysmal Nocturnal Hemoglobinuria Treatment 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Paroxysmal Nocturnal Hemoglobinuria Treatment Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Paroxysmal Nocturnal Hemoglobinuria Treatment Major Manufacturers in 2017 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Value and Volume) Forecast (2018-2025) 11.1 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume, Revenue Forecast (2018-2025) 11.2 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume Forecast by Type (2018-2025) 11.3 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume Forecast by Application (2018-2025) 11.4 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume Forecast by Region (2018-2025) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Paroxysmal Nocturnal Hemoglobinuria Treatment Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (K Pcs) by Type (2013-2025) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume Market Share by Type (Product Category) in 2017 Figure ACH-4471 Product Picture Figure ALN-CC5 Product Picture Figure ALXN-1210 Product Picture Figure AMY-101 Product Picture Figure APL-2 Product Picture Figure Others Product Picture Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (K Pcs) by Application (2013-2025) Figure United States Sales Market Share of Paroxysmal Nocturnal Hemoglobinuria Treatment by Application in 2017 Figure Hospital Examples Table Key Downstream Customer in Hospital Figure Clinic Examples Table Key Downstream Customer in Clinic Figure Others Examples Table Key Downstream Customer in Others Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Million USD) by Region (2013-2025) Figure The West Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Growth Rate (2013-2025) Figure Southwest Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Growth Rate (2013-2025) Figure The Middle Atlantic Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Growth Rate (2013-2025) Figure New England Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Growth Rate (2013-2025) Figure The South of US Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Growth Rate (2013-2025) Figure The Midwest Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Growth Rate (2013-2025) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) and Growth Rate (2013-2025) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Growth Rate (2013-2025) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Major Players Product Sales Volume (K Pcs) (2013-2018) Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) of Key Players/Suppliers (2013-2018) Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Share by Players/Suppliers (2013-2018) Figure 2017 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Share by Players/Suppliers Figure 2017 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Share by Players/Suppliers Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Major Players Product Revenue (Million USD) (2013-2018) Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) by Players/Suppliers (2013-2018) Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Share by Players/Suppliers (2013-2018) Figure 2017 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Share by Players/Suppliers Figure 2017 United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Share by Players/Suppliers Table United States Market Paroxysmal Nocturnal Hemoglobinuria Treatment Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018) Figure United States Market Paroxysmal Nocturnal Hemoglobinuria Treatment Average Price (USD/Pcs) of Key Players/Suppliers in 2017 Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share of Top 3 Players/Suppliers Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share of Top 5 Players/Suppliers Table United States Players/Suppliers Paroxysmal Nocturnal Hemoglobinuria Treatment Manufacturing Base Distribution and Sales Area Table United States Players/Suppliers Paroxysmal Nocturnal Hemoglobinuria Treatment Product Category Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) by Region (2013-2018) Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Share by Region (2013-2018) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Share by Region (2013-2018) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Region in 2017 Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Market Share by Region (2013-2018) Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Share by Region (2013-2018) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Region (2013-2018) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Region in 2017 Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Price (USD/Pcs) by Region (2013-2018) Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) by Type (2013-2018) Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Share by Type (2013-2018) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Share by Type (2013-2018) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Type in 2017 Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Market Share by Type (2013-2018) Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Share by Type (2013-2018) Figure Revenue Market Share of Paroxysmal Nocturnal Hemoglobinuria Treatment by Type (2013-2018) Figure Revenue Market Share of Paroxysmal Nocturnal Hemoglobinuria Treatment by Type in 2017 Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Price (USD/Pcs) by Types (2013-2018) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Growth Rate by Type (2013-2018) Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs) by Application (2013-2018) Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Application (2013-2018) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Application (2013-2018) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share by Application in 2017 Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Growth Rate by Application (2013-2018) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Growth Rate by Application (2013-2018) Table Achillion Pharmaceuticals Inc Basic Information List Table Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Growth Rate (2013-2018) Figure Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in United States (2013-2018) Figure Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in United States (2013-2018) Table Akari Therapeutics Plc Basic Information List Table Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Growth Rate (2013-2018) Figure Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in United States (2013-2018) Figure Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in United States (2013-2018) Table Alexion Pharmaceuticals Inc Basic Information List Table Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Growth Rate (2013-2018) Figure Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in United States (2013-2018) Figure Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in United States (2013-2018) Table Alnylam Pharmaceuticals Inc Basic Information List Table Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Growth Rate (2013-2018) Figure Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in United States (2013-2018) Figure Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in United States (2013-2018) Table Amgen Inc Basic Information List Table Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Growth Rate (2013-2018) Figure Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in United States (2013-2018) Figure Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in United States (2013-2018) Table Apellis Pharmaceuticals Inc Basic Information List Table Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Growth Rate (2013-2018) Figure Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in United States (2013-2018) Figure Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in United States (2013-2018) Table F. Hoffmann-La Roche Ltd Basic Information List Table F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Growth Rate (2013-2018) Figure F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in United States (2013-2018) Figure F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in United States (2013-2018) Table ISU ABXIS Co Ltd Basic Information List Table ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Growth Rate (2013-2018) Figure ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in United States (2013-2018) Figure ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in United States (2013-2018) Table Novartis AG Basic Information List Table Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Growth Rate (2013-2018) Figure Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in United States (2013-2018) Figure Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in United States (2013-2018) Table NovelMed Therapeutics Inc Basic Information List Table NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Growth Rate (2013-2018) Figure NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Market Share in United States (2013-2018) Figure NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share in United States (2013-2018) Table Omeros Corp Basic Information List Table Ra Pharmaceuticals Inc Basic Information List Table Regeneron Pharmaceuticals Inc Basic Information List Table Regenesance BV Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Paroxysmal Nocturnal Hemoglobinuria Treatment Figure Manufacturing Process Analysis of Paroxysmal Nocturnal Hemoglobinuria Treatment Figure Paroxysmal Nocturnal Hemoglobinuria Treatment Industrial Chain Analysis Table Raw Materials Sources of Paroxysmal Nocturnal Hemoglobinuria Treatment Major Players/Suppliers in 2017 Table Major Buyers of Paroxysmal Nocturnal Hemoglobinuria Treatment Table Distributors/Traders List Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Price (USD/Pcs) Trend Forecast (2018-2025) Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume (K Pcs) Forecast by Type (2018-2025) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume (K Pcs) Forecast by Type (2018-2025) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume (K Pcs) Forecast by Type in 2025 Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume (K Pcs) Forecast by Application (2018-2025) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume (K Pcs) Forecast by Application (2018-2025) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume (K Pcs) Forecast by Application in 2025 Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume (K Pcs) Forecast by Region (2018-2025) Table United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume Share Forecast by Region (2018-2025) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume Share Forecast by Region (2018-2025) Figure United States Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Volume Share Forecast by Region in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources